Condition
Red Blood Cell
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed2
Recruiting1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06560164Not ApplicableRecruiting
Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMO
NCT06878040Completed
Effect of Baseline Ferritin Level on Iron Status in Male Elite Youth Rowers
NCT04537000Not ApplicableWithdrawn
Individualized Strategies of Red Blood Cell Transfusion for Perioperative Pediatric Patients
NCT02272530CompletedPrimary
Analysis of Proteome and Pathophysiological Characteristics of Human Blood Cells
Showing all 4 trials